CaRi-Heart® technology creates a new paradigm to fight heart attack and other cardiac diseases by uncovering hidden inflammation.

Improve Prevention

Optimise Diagnosis and Treatment

Support Drug Development

CaRi-Heart® Coronary Inflammation Technology Authorized by U.S. FDA

First and only biomarker to measure coronary inflammation and assess cardiovascular mortality risk, enabling personalized disease management.

Read Press Release